Get started
444

TAIWAN ADVANCE BIO-PHARM INC

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

4186 chart


Full chart

Key stats


Market capitalization
‪1.42 B‬ TWD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
66.45
Basic EPS (TTM)
0.25 TWD
Net income (FY)
‪−10.68 M‬ TWD
Revenue (FY)
‪315.98 M‬ TWD
Shares float
‪68.11 M‬
Beta (1Y)
−0.15

Employees


Employees (FY)
154
Change (1Y)
0
Revenue / Employee (1Y)
‪66.84 K‬ TWD
Net income / Employee (1Y)
‪−2.26 K‬ TWD

About TAIWAN ADVANCE BIO-PHARM INC


Sector
Health Technology
Industry
Medical Specialties
CEO
Wen Lung Su
Website
biotest.com.tw
Headquarters
Taipei
Founded
2000
ISIN
TW0004186002
FIGI
BBG003NBBV11
Taiwan Advance Bio-Pharmaceutical, Inc. engages in the research, development, production, and sale of drug residue testing reagents. It operates through the following business segments: Inspection business, Food safety, Precision medicine, Research and development unit 2, and New business. The Inspection business segment offers drug abuse certification testing services. The Food safety segment offers drug residue detection reagents. The Precision medicine segment provides cord blood preservation as well as testing and cord blood gene related customer services. The Research and development unit 2 segment includes the development of new drugs and hematopoietic stem cell proliferation technology. The New business segment offers genetic testing and business services. The company was founded on May 25, 2000 and is headquartered in Taipei, Taiwan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4186 is 15.65 TWD — it has decreased by −2.53% in the past 24 hours. Watch TAIWAN ADVANCE BIO-PHARM INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange TAIWAN ADVANCE BIO-PHARM INC stocks are traded under the ticker 4186.
4186 stock has fallen by −1.91% compared to the previous week, the month change is a 2.33% rise, over the last year TAIWAN ADVANCE BIO-PHARM INC has showed a −8.48% decrease.
4186 reached its all-time high on Nov 28, 2012 with the price of 77.90 TWD, and its all-time low was 11.35 TWD and was reached on Mar 19, 2020. View more price dynamics on 4186 chart.
See other stocks reaching their highest and lowest prices.
4186 stock is 1.61% volatile and has beta coefficient of −0.15. Track TAIWAN ADVANCE BIO-PHARM INC stock price on the chart and check out the list of the most volatile stocks — is TAIWAN ADVANCE BIO-PHARM INC there?
Today TAIWAN ADVANCE BIO-PHARM INC has the market capitalization of ‪1.39 B‬, it has decreased by −3.45% over the last week.
Yes, you can track TAIWAN ADVANCE BIO-PHARM INC financials in yearly and quarterly reports right on TradingView.
4186 net income for the last half-year is ‪−4.41 M‬ TWD, while the previous report showed ‪25.82 M‬ TWD of net income which accounts for −117.09% change. Track more TAIWAN ADVANCE BIO-PHARM INC financial stats to get the full picture.
No, 4186 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 154.00 employees. See our rating of the largest employees — is TAIWAN ADVANCE BIO-PHARM INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TAIWAN ADVANCE BIO-PHARM INC EBITDA is ‪43.66 M‬ TWD, and current EBITDA margin is 6.07%. See more stats in TAIWAN ADVANCE BIO-PHARM INC financial statements.
Like other stocks, 4186 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TAIWAN ADVANCE BIO-PHARM INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TAIWAN ADVANCE BIO-PHARM INC technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TAIWAN ADVANCE BIO-PHARM INC stock shows the sell signal. See more of TAIWAN ADVANCE BIO-PHARM INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.